COMMUNIQUÉS West-GlobeNewswire

BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in the United States
15/11/2018
MELVILLE, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the [...]
Sales of Olainfarm in October Grew by 34%
15/11/2018
Preliminary consolidated results of JSC Olainfarm for October 2018 show that company’s sales have reached 12.78 million euros, which represents an increase by 34% compared to the same period of 2017. Over the ten-month [...]
Diffusion Pharmaceuticals Chief Scientific Officer Dr. John L. Gainer to Present at 2018 Annual Meeting of the Society for NeuroOncology
15/11/2018
Poster Presentation to Focus on Phase 3 GBM Brain Cancer Clinical Trial; 40 Percent Survival Rate for Biopsy-only Patients in Phase 2 Represents Fourfold Increase Above Historical Average For Those Facing Inoperable GBM [...]
Key Weight Loss and Safety Data Presented for the Obalon Swallowable Gas-Filled Balloon System at the 35th ASMBS Annual Meeting at Obesity Week 2018
15/11/2018
Clinical results presented from over 1,300 patients treated at 108 sites with Obalon’s non-surgical weight loss solution in commercial setting SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. ( [...]
Milestone Scientific Provides Business Update for the Third Quarter of 2018
15/11/2018
LIVINGSTON, N.J., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a [...]
Hemispherx Reports 2018 Third Quarter and First Nine Months Financial Results
15/11/2018
OCALA, Fla., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announces financial results for the three and nine months ended September 30, 2018, and provides a business update. [...]
LEARN Behavioral Announces Partnership with Cognoa to Empower Parents and Enable Earlier Diagnosis
15/11/2018
BALTIMORE, Md. and PALO ALTO, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- LEARN Behavioral , the leading network of providers serving children with autism and other special needs, today announces a partnership with [...]
Zealand Pharma - Interim report for the first nine months of 2018
15/11/2018
Company announcement - No. 28 / 2018 Zealand Pharma - Interim report for the first nine months of 2018 Copenhagen, November 15, 2018 - Zealand Pharma A/S ("Zealand") (Nasdaq: ZEAL) (Company reg. No. 20 04 50 78), a [...]
NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration
15/11/2018
In 2014 the Company entered into a license agreement with Merck to develop, manufacture and commercialize NewLink Genetics’ Ebola vaccine candidate AMES, Iowa, Nov. 15, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics [...]
Medigus Board of Directors Announces Cost Reduction Measures
15/11/2018
OMER, Israel, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct [...]
Akari Announces Coversin Data to be Presented at 2018 Complement-Based Drug Development Summit
15/11/2018
Highlights potential role of both complement and leukotriene pathways in a therapeutic mouse model of rheumatoid arthritis (RA) NEW YORK and LONDON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX [...]
With Industrial-Scale Tissue Culture Production Process, NewBridge Global Ventures Creates Vital Link In Cannabis & Hemp Industry Chain -- CFN Media
15/11/2018
Seattle, WA, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Cabaletta Bio Expands Scientific Regulatory, and Cell Therapy Manufacturing Expertise with Scientific Advisory Board Additions
15/11/2018
-- Carl June, M.D., who led discovery and development of the breakthrough CAR T platform at the University of Pennsylvania -- Jay Siegel, M.D., former head of Office of Therapeutics Research and Review, Center for [...]
Precipio Announces Third Quarter 2018 Corporate Update Call for Shareholders
15/11/2018
Conference Call to Be Held Monday, November 19, 2018 at 5:00 PM ET NEW HAVEN, Conn., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) will be hosting its third [...]
Helius Medical Technologies, Inc. Announces Pricing of Public Offering of Class A Common Stock
15/11/2018
NEWTOWN, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,121,212 shares of [...]
VPR Brands, LP Announces Third Quarter 2018 Results
15/11/2018
FORT LAUDERDALE, FL, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- VPR Brands, LP (OTC PINK: VPRB) (“VPR Brands”), a market leader in innovation specializing in accessories and vaporizers for essential oils, [...]
Cannabix Technologies Engages MistyWest - Provides Development Update on Marijuana Breathalyzer
15/11/2018
The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE [...]
Novo Nordisk A/S - Share repurchase programme
15/11/2018
Bagsværd, Denmark, 15 November 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
TRACON Pharmaceuticals Presents New Circulating Tumor Cell Data from Ongoing Pivotal Phase 3 TAPPAS Trial of TRC105 and Votrient® in Patients with Angiosarcoma
15/11/2018
Changes in Endoglin Expressing Circulating Tumor Cells (CTC) Detected in Phase 3 TAPPAS Trial Changes in CTC count may be useful as a prognostic biomarker and baseline CTC may be useful as a predictive biomarker SAN [...]

Pages